BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 36241547)

  • 1. In vivo application of base and prime editing to treat inherited retinal diseases.
    Jo DH; Bae S; Kim HH; Kim JS; Kim JH
    Prog Retin Eye Res; 2023 May; 94():101132. PubMed ID: 36241547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic Gene Editing in Inherited Retinal Disorders.
    Ling J; Jenny LA; Zhou A; Tsang SH
    Cold Spring Harb Perspect Med; 2023 Apr; 13(4):. PubMed ID: 36096547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene editing prospects for treating inherited retinal diseases.
    Benati D; Patrizi C; Recchia A
    J Med Genet; 2020 Jul; 57(7):437-444. PubMed ID: 31857428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Future Perspectives of Prime Editing for the Treatment of Inherited Retinal Diseases.
    Hansen S; McClements ME; Corydon TJ; MacLaren RE
    Cells; 2023 Jan; 12(3):. PubMed ID: 36766782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Base and Prime Editing in the Retina-From Preclinical Research toward Human Clinical Trials.
    Yee T; Wert KJ
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prime Editing for the Installation and Correction of Mutations Causing Inherited Retinal Disease: A Brief Methodology.
    Tsai YT; da Costa BL; Nolan ND; Caruso SM; Jenny LA; Levi SR; Tsang SH; Quinn PMJ
    Methods Mol Biol; 2023; 2560():313-331. PubMed ID: 36481907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prime Editing for Inherited Retinal Diseases.
    da Costa BL; Levi SR; Eulau E; Tsai YT; Quinn PMJ
    Front Genome Ed; 2021; 3():775330. PubMed ID: 34901928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRISPR/Cas9 genome surgery for retinal diseases.
    Xu CL; Park KS; Tsang SH
    Drug Discov Today Technol; 2018 Aug; 28():23-32. PubMed ID: 30205877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New Editing Tools for Gene Therapy in Inherited Retinal Dystrophies.
    Pulman J; Sahel JA; Dalkara D
    CRISPR J; 2022 Jun; 5(3):377-388. PubMed ID: 35506982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR base editors: genome editing without double-stranded breaks.
    Eid A; Alshareef S; Mahfouz MM
    Biochem J; 2018 Jun; 475(11):1955-1964. PubMed ID: 29891532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo somatic cell base editing and prime editing.
    Newby GA; Liu DR
    Mol Ther; 2021 Nov; 29(11):3107-3124. PubMed ID: 34509669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene Editing With TALEN and CRISPR/Cas in Rice.
    Bi H; Yang B
    Prog Mol Biol Transl Sci; 2017; 149():81-98. PubMed ID: 28712502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRISPR genome engineering for retinal diseases.
    Kantor A; McClements ME; Peddle CF; Fry LE; Salman A; Cehajic-Kapetanovic J; Xue K; MacLaren RE
    Prog Mol Biol Transl Sci; 2021; 182():29-79. PubMed ID: 34175046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
    Soriano V
    AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and application of CRISPR/Cas9 technologies in genomic editing.
    Zhang C; Quan R; Wang J
    Hum Mol Genet; 2018 Aug; 27(R2):R79-R88. PubMed ID: 29659822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress in the application of CRISPR: From gene to base editing.
    Wu W; Yang Y; Lei H
    Med Res Rev; 2019 Mar; 39(2):665-683. PubMed ID: 30171624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guiding Lights in Genome Editing for Inherited Retinal Disorders: Implications for Gene and Cell Therapy.
    Sanjurjo-Soriano C; Kalatzis V
    Neural Plast; 2018; 2018():5056279. PubMed ID: 29853845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoparticles-mediated CRISPR-Cas9 gene therapy in inherited retinal diseases: applications, challenges, and emerging opportunities.
    Chien Y; Hsiao YJ; Chou SJ; Lin TY; Yarmishyn AA; Lai WY; Lee MS; Lin YY; Lin TW; Hwang DK; Lin TC; Chiou SH; Chen SJ; Yang YP
    J Nanobiotechnology; 2022 Dec; 20(1):511. PubMed ID: 36463195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prime editing in plants and mammalian cells: Mechanism, achievements, limitations, and future prospects.
    Hillary VE; Ceasar SA
    Bioessays; 2022 Sep; 44(9):e2200032. PubMed ID: 35750651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basic Principles and Clinical Applications of CRISPR-Based Genome Editing.
    Lim JM; Kim HH
    Yonsei Med J; 2022 Feb; 63(2):105-113. PubMed ID: 35083895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.